Guidelines-Based Use of Thromboprophylaxis

Disclosure: The authors received honoraria for their work on this Supplement. This activity is Supported by an educational grant from sanofi-aventis U.S. The commercial supporter had no influence of the content and provided no role in the preparation of the manuscripts. All coauthors were involved in the conception and design, critical revisions, and final approval of the manuscripts within this Supplement. All coauthors have seen and agree with the contents of the manuscripts. The submission is not under review by any other publication. The authors and continuing medical education (CME) activity planners have indicated the following financial relationships, which have been resolved through an established conflict of interest resolution process, and have stated that these reported relationships will not have any impact on their ability to provide unbiased content. Authors: S.B.D: consulting fees/advisory boards: Bristol-Myers Squibb, Scios Inc., sanofi-aventis U.S.; fees received for promotional/non-CME activities: sanofi-aventis U.S.; contracted research: Bayer Health Care, sanofi-aventis U.S. A.S.: consulting fees/advisory boards: Gerson Lehrman Group. EM.: consulting fees/advisory boards: sanofi-aventis U.S., Scios Inc.; fees received for promotional/non-CME activities: sanofi-aventis U.S., Scios Inc., Genentech. S.C.M.: consulting fees/advisory boards: sanofi-aventis U.S. A.J. has no financial relationships to disclose. CME Activity Planners: Rachel A. Karcher, PharmD, content manager at Med-IQ, has no financial relationships to disclose; Gregory M. Masters, associate managing editor at Med-IQ, has no financial relationships to disclose. Editorial assistance for all 4 articles in this Supplement was provided by: A.J., Rachel Karcher, Gregory Masters, and Lisa R. Rinehart, MS, ELS.